NCT04681105 2026-01-28
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
Phase 1 Completed
City of Hope Medical Center
Washington University School of Medicine
Strategic Science & Technologies, LLC
Kythera Biopharmaceuticals